000 01363 a2200385 4500
005 20250518005134.0
264 0 _c20190528
008 201905s 0 0 eng d
022 _a1434-9949
024 7 _a10.1007/s10067-018-4357-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTamanini, Silvia
245 0 0 _aLetter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease.
_h[electronic resource]
260 _bClinical rheumatology
_cFeb 2019
300 _a609-610 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aArthralgia
_xetiology
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecurrence
650 0 4 _aSpondylarthritis
_xetiology
700 1 _aFredi, Micaela
700 1 _aCrisafulli, Francesca
700 1 _aLazzaroni, Maria Grazia
700 1 _aTincani, Angela
700 1 _aFranceschini, Franco
773 0 _tClinical rheumatology
_gvol. 38
_gno. 2
_gp. 609-610
856 4 0 _uhttps://doi.org/10.1007/s10067-018-4357-y
_zAvailable from publisher's website
999 _c29014183
_d29014183